Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Balta Group N.V. | BALTA | Oct 30, 2024 | 1.36 | 0.00 |
Banco Bilbao Vizcaya Argentaria SA | BBV | Oct 30, 2024 | 7.80 | 0.00 |
Banco Santander SA | SANTA | Oct 30, 2024 | 3.58 | 0.00 |
Banimmo SA | BANI | Oct 30, 2024 | 2.96 | -0.67 |
Banque Nationale de Belgique | BNB | Oct 30, 2024 | 416.00 | 0.00 |
Barco NV | BAR | Oct 30, 2024 | 11.45 | -0.35 |
Basilix | BAS | Oct 30, 2024 | 24.80 | 0.00 |
Beaulieu Av Certificates | BEAB | Oct 30, 2024 | 1.19 | 0.00 |
Befimmo SA | BEFB | Oct 30, 2024 | 46.10 | 0.00 |
Bel20 | BEL20 | Oct 30, 2024 | 4 229.83 | -1.27 |
Belreca - Belgian Resources and Capital Company | BELR | Oct 30, 2024 | 7.50 | 0.00 |
Beluga NV | BELU | Oct 30, 2024 | 1.50 | 0.00 |
Belysse Group N.V. | BELYS | Oct 30, 2024 | 0.84 | -0.59 |
Biocartis Group NV | BCART | Oct 30, 2024 | 0.29 | 0.00 |
Biosenic | BIOS | Oct 30, 2024 | 0.01 | -15.12 |
Biotalys | BTLS | Oct 30, 2024 | 3.12 | -0.95 |
Boeing | BOEI | Oct 30, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | Oct 30, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | Oct 30, 2024 | 2.31 | -1.91 |
Brederode S.A. | BREB | Oct 30, 2024 | 108.00 | +0.37 |
Campine nv | CAMB | Oct 30, 2024 | 86.00 | 0.00 |
Candela Invest | CAND | Oct 30, 2024 | 1.33 | 0.00 |
Care Property Invest NV/SA | CPINV | Oct 30, 2024 | 12.68 | -0.31 |
Celyad Oncology SA | CYAD | Oct 30, 2024 | 0.27 | +4.17 |
Cenergy Holdings | CENER | Oct 30, 2024 | 8.95 | +4.07 |
Chevron | CHTEX | Oct 30, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | Oct 30, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | Oct 30, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | Oct 30, 2024 | 58.95 | -1.42 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | Oct 30, 2024 | 127.00 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.